2.15
제2형 당뇨병(T2DM)은 인슐린 저항성을 특징으로 하는 만성 대사 질환으로, 간, 근육, 지방 조직과 같은 표적 조직이 인슐린에 잘 반응하지 않습니다. 또한 췌장 β세포가 충분한 인슐린을 생산하지 못하는 보상성 인슐린 분비 부족과도 관련이 있습니다. 이러한 이상들이…
제2형 당뇨병은 두 가지 주요 결함이 특징인 만성 대사 질환입니다: 인슐린 저항성(조직이 인슐린에 잘 반응하지 않음)과 진행성 베타세포 기능 장애(췌장이 충분한 인슐린을 분비하지 못해 정상 혈당 유지에 실패해 고혈당을 유발하는 질환)입니다.
유전적 소인과 환경적 요인이 복합적으로 작용하여 발달합니다.
후생유전학적 변화는 대사 조절 장애에도 기여하여 FTO와 TCF7L2와 같은 유전자의 발현에 영향을 미칩니다.
비만, 신체 활동 부족, 건강하지 못한 식습관과 같은 환경적 요인은 염증과 산화 스트레스를 증가시켜 인슐린 저항성을 악화시킵니다.
유전자-환경 상호작용은 위험을 더욱 높입니다.
예를 들어, KCNQ1 변이를 가진 사람들은 고지방 식단에 노출될 경우 당뇨병 위험이 더 높을 수 있습니다.
고령, 가족력, 인종, 중추성 비만, 고혈압, 임신성 당뇨병과 같은 위험 요인은 제2형 당뇨병 발병 가능성을 높입니다.
View the full transcript and gain access to JoVE Core videos
Q1: What are the two main defects that characterize type 2 diabetes mellitus?
Type 2 diabetes mellitus is characterized by insulin resistance, where tissues like the liver, muscle, and adipose tissue respond poorly to insulin, and progressive beta cell dysfunction, where pancreatic beta cells fail to produce sufficient insulin. Together, these abnormalities result in persistent hyperglycemia, the hallmark of the disease.
Q2: How do genetic and environmental factors interact to increase type 2 diabetes risk?
Type 2 diabetes develops through complex interactions between genetic predisposition and environmental triggers. Certain genetic variants, such as KCNQ1, have stronger effects when combined with environmental stressors like high-fat diets. Gene-environment interactions raise disease risk through additive and synergistic mechanisms, meaning both factors together amplify susceptibility beyond their individual effects.
Q3: What role do epigenetic changes play in type 2 diabetes development?
Epigenetic changes contribute to impaired metabolic regulation by influencing the expression of genes such as FTO and TCF7L2. Environmental factors including obesity, physical inactivity, and unhealthy diets promote chronic inflammation and oxidative stress, which trigger these epigenetic modifications that worsen insulin resistance and increase disease risk.
Q4: Which non-modifiable risk factors increase the likelihood of developing type 2 diabetes?
Non-modifiable risk factors include family history, advanced age over 45, high-risk ethnicities such as South Asian, Hispanic, African, and Indigenous populations, and genetic susceptibility including rare monogenic forms like maturity-onset diabetes of the young. These factors cannot be changed but help identify individuals at elevated risk.
Q5: How do lifestyle factors like obesity and physical inactivity contribute to type 2 diabetes?
Obesity, especially visceral fat accumulation, and physical inactivity worsen insulin resistance by promoting chronic inflammation, oxidative stress, and hormonal imbalance. These environmental factors trigger epigenetic changes affecting metabolic genes and increase disease risk through multiple pathways, making them significant modifiable risk factors.
Q6: What cardiometabolic conditions increase the risk of type 2 diabetes?
Cardiometabolic conditions such as hypertension, dyslipidemia, and a history of gestational diabetes or polycystic ovarian syndrome further increase type 2 diabetes risk. These conditions reflect underlying metabolic dysfunction and often coexist with insulin resistance, compounding disease susceptibility through shared pathophysiological mechanisms.
Q7: What additional lifestyle and environmental factors contribute to type 2 diabetes risk beyond diet and exercise?
Poor sleep, smoking, alcohol use, socioeconomic stress, and environmental pollutants disrupt metabolic regulation and increase type 2 diabetes risk. These factors work alongside modifiable factors like central obesity and sedentary lifestyle to impair glucose homeostasis and promote disease development through multiple metabolic pathways.